Titre : Dystonie

Dystonie : Questions médicales fréquentes

Termes MeSH sélectionnés :

Reproducibility of Results
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Dystonie : Questions médicales les plus fréquentes", "headline": "Dystonie : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Dystonie : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-28", "dateModified": "2025-03-25", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Dystonie" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Dyskinésies", "url": "https://questionsmedicales.fr/mesh/D020820", "about": { "@type": "MedicalCondition", "name": "Dyskinésies", "code": { "@type": "MedicalCode", "code": "D020820", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.350" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Torticolis", "alternateName": "Torticollis", "url": "https://questionsmedicales.fr/mesh/D014103", "about": { "@type": "MedicalCondition", "name": "Torticolis", "code": { "@type": "MedicalCode", "code": "D014103", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.350.300.800" } } } ], "about": { "@type": "MedicalCondition", "name": "Dystonie", "alternateName": "Dystonia", "code": { "@type": "MedicalCode", "code": "D004421", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "H A Jinnah", "url": "https://questionsmedicales.fr/author/H%20A%20Jinnah", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Alfredo Berardelli", "url": "https://questionsmedicales.fr/author/Alfredo%20Berardelli", "affiliation": { "@type": "Organization", "name": "From the Departments of Biomedical Engineering (A.G.S., S.B.B.) and Neurology (A.G.S.), Case Western University School of Medicine; Neurological Institute (A.G.S.), University Hospitals Cleveland; Neurology Service (A.G.S.), Louis Stokes Cleveland VA Medical Center, OH; Department of Neurology (L.S., G.K.-B., A.F., S. Factor, H.A.J.), Human Genetics (H.A.J.), and Pediatrics (H.A.J.), Emory University School of Medicine, Atlanta, GA; Institute of Neurogenetics (C.K., J.J., S.L., N.B., A.M., T.B.), University of Lübeck, Germany; Department of Neurology (M.V., E.R., C.B.), Pitié-Salpêtrière Hospital, Paris, France; Department of Neurology (J.J.), Baylor College of Medicine, Houston, TX; Neurology and Neurosurgery (J.J.-S.), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Neurology (N.P.), Henry Ford Health System, West Bloomfield, MI; Department of Psychiatry and Neurology (L.M.), Baylor College of Medicine, Houston, TX; Department of Neurological Sciences (C.C.), Rush University Medical Center, Chicago, IL; Department of Neurology (R.L.B.), University of Rochester, NY; Department of Neurology (B.D.B.), University of Colorado School of Medicine, Aurora; Department of Neurology (I.M., A.W.S.), Norman Fixel Institute for Neurological Diseases, University of Florida, Gainesville; Department of Neurology (S.G.R.), University of Maryland School of Medicine, Baltimore; University of Tennessee Health Science Center (M.S.L.), Memphis; Department of Neurosciences (A.B.), Mental Health and Sensory Organs, Suicide Prevention Center, Sant'Andrea Hospital, Sapienza University of Rome; IRCCS Neuromed (G.F.), Pozzilli, Italy; The University of Alabama at Birmingham (N.S.); Methodist Neurological Institute (W.O.), Houston, TX; Department of Neurology (S.P.R.), University of New Mexico Health Sciences Center, Albuquerque; Department of Neurology (R.S.-P.), Mount Sinai Beth Israel, New York, NY; Lou Ruvo Center for Brain Health (Z.M.), Cleveland Clinic, Las Vegas, NV; Booth Gardner Parkinson's Care Center (P.A.), Kirkland, WA; Mayo Clinic (C.A.), Scottsdale, AZ; Andre Barbeau Movement Disorders Unit (S.C.), Montreal University Hospital Center (CHUM); Movement Disorder Clinic (S.H.F.), Toronto Western Hospital, Division of Neurology University of Toronto, Canada; UC Davis School of Medicine (A.B.), Sacramento; The Parkinson's and Movement Disorder Institute (D.T.), Orange Coast Memorial Medical Center, Fountain Valley, CA; Department of Medicine (O.S.), Medical Genetics, and Pediatrics, University of Alberta, Canada; Department of Neurology (S. Frank), Beth Israel Deaconess Medical Center, Boston, MA; and Neurology, Radiology, Neuroscience, Physical Therapy and Occupational Therapy (J.P.), Washington University School of Medicine, St Louis, MO." } }, { "@type": "Person", "name": "Michael Zech", "url": "https://questionsmedicales.fr/author/Michael%20Zech", "affiliation": { "@type": "Organization", "name": "Institute of Neurogenomics, Helmholtz Zentrum München, Munich, Germany; Technical University of Munich, School of Medicine, Institute of Human Genetics, Munich, Germany. Electronic address: michael.zech@mri.tum.de." } }, { "@type": "Person", "name": "Gamze Kilic-Berkmen", "url": "https://questionsmedicales.fr/author/Gamze%20Kilic-Berkmen", "affiliation": { "@type": "Organization", "name": "From the Departments of Biomedical Engineering (A.G.S., S.B.B.) and Neurology (A.G.S.), Case Western University School of Medicine; Neurological Institute (A.G.S.), University Hospitals Cleveland; Neurology Service (A.G.S.), Louis Stokes Cleveland VA Medical Center, OH; Department of Neurology (L.S., G.K.-B., A.F., S. Factor, H.A.J.), Human Genetics (H.A.J.), and Pediatrics (H.A.J.), Emory University School of Medicine, Atlanta, GA; Institute of Neurogenetics (C.K., J.J., S.L., N.B., A.M., T.B.), University of Lübeck, Germany; Department of Neurology (M.V., E.R., C.B.), Pitié-Salpêtrière Hospital, Paris, France; Department of Neurology (J.J.), Baylor College of Medicine, Houston, TX; Neurology and Neurosurgery (J.J.-S.), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Neurology (N.P.), Henry Ford Health System, West Bloomfield, MI; Department of Psychiatry and Neurology (L.M.), Baylor College of Medicine, Houston, TX; Department of Neurological Sciences (C.C.), Rush University Medical Center, Chicago, IL; Department of Neurology (R.L.B.), University of Rochester, NY; Department of Neurology (B.D.B.), University of Colorado School of Medicine, Aurora; Department of Neurology (I.M., A.W.S.), Norman Fixel Institute for Neurological Diseases, University of Florida, Gainesville; Department of Neurology (S.G.R.), University of Maryland School of Medicine, Baltimore; University of Tennessee Health Science Center (M.S.L.), Memphis; Department of Neurosciences (A.B.), Mental Health and Sensory Organs, Suicide Prevention Center, Sant'Andrea Hospital, Sapienza University of Rome; IRCCS Neuromed (G.F.), Pozzilli, Italy; The University of Alabama at Birmingham (N.S.); Methodist Neurological Institute (W.O.), Houston, TX; Department of Neurology (S.P.R.), University of New Mexico Health Sciences Center, Albuquerque; Department of Neurology (R.S.-P.), Mount Sinai Beth Israel, New York, NY; Lou Ruvo Center for Brain Health (Z.M.), Cleveland Clinic, Las Vegas, NV; Booth Gardner Parkinson's Care Center (P.A.), Kirkland, WA; Mayo Clinic (C.A.), Scottsdale, AZ; Andre Barbeau Movement Disorders Unit (S.C.), Montreal University Hospital Center (CHUM); Movement Disorder Clinic (S.H.F.), Toronto Western Hospital, Division of Neurology University of Toronto, Canada; UC Davis School of Medicine (A.B.), Sacramento; The Parkinson's and Movement Disorder Institute (D.T.), Orange Coast Memorial Medical Center, Fountain Valley, CA; Department of Medicine (O.S.), Medical Genetics, and Pediatrics, University of Alberta, Canada; Department of Neurology (S. Frank), Beth Israel Deaconess Medical Center, Boston, MA; and Neurology, Radiology, Neuroscience, Physical Therapy and Occupational Therapy (J.P.), Washington University School of Medicine, St Louis, MO." } }, { "@type": "Person", "name": "Roberto Erro", "url": "https://questionsmedicales.fr/author/Roberto%20Erro", "affiliation": { "@type": "Organization", "name": "Department of Medicine, Surgery and Dentistry \"Scuola Medica Salernitana\", University of Salerno, Baronissi (SA), Italy." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Twelve-month results of the ADAPT randomized controlled trial: Reproducibility and sustainability of advanced hybrid closed-loop therapy outcomes versus conventional therapy in adults with type 1 diabetes.", "datePublished": "2023-08-08", "url": "https://questionsmedicales.fr/article/37551542", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/dom.15217" } }, { "@type": "ScholarlyArticle", "name": "Reproducibility and intratumoral heterogeneity of the PAM50 breast cancer assay.", "datePublished": "2023-03-09", "url": "https://questionsmedicales.fr/article/36892725", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s10549-023-06888-1" } }, { "@type": "ScholarlyArticle", "name": "Grading of Medullary Thyroid Carcinoma: an Interobserver Reproducibility Study.", "datePublished": "2022-05-13", "url": "https://questionsmedicales.fr/article/35553368", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s12022-022-09718-0" } }, { "@type": "ScholarlyArticle", "name": "Reproducible Abnormalities and Diagnostic Generalizability of White Matter in Alzheimer's Disease.", "datePublished": "2023-04-04", "url": "https://questionsmedicales.fr/article/37014553", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s12264-023-01041-w" } }, { "@type": "ScholarlyArticle", "name": "Support academic access to automated cloud labs to improve reproducibility.", "datePublished": "2023-01-03", "url": "https://questionsmedicales.fr/article/36595506", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pbio.3001919" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "États, signes et symptômes pathologiques", "item": "https://questionsmedicales.fr/mesh/D013568" }, { "@type": "ListItem", "position": 3, "name": "Signes et symptômes", "item": "https://questionsmedicales.fr/mesh/D012816" }, { "@type": "ListItem", "position": 4, "name": "Manifestations neurologiques", "item": "https://questionsmedicales.fr/mesh/D009461" }, { "@type": "ListItem", "position": 5, "name": "Dyskinésies", "item": "https://questionsmedicales.fr/mesh/D020820" }, { "@type": "ListItem", "position": 6, "name": "Dystonie", "item": "https://questionsmedicales.fr/mesh/D004421" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Dystonie - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Dystonie", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-11", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Dystonie", "description": "Comment diagnostique-t-on la dystonie ?\nQuels tests sont utilisés pour la dystonie ?\nLa dystonie est-elle héréditaire ?\nQuels spécialistes consultent pour la dystonie ?\nY a-t-il des critères spécifiques pour le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D004421?mesh_terms=Reproducibility+of+Results&page=5#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Dystonie", "description": "Quels sont les symptômes courants de la dystonie ?\nLa dystonie affecte-t-elle la parole ?\nLes symptômes de la dystonie sont-ils constants ?\nLa dystonie peut-elle causer de la douleur ?\nY a-t-il des types spécifiques de dystonie ?", "url": "https://questionsmedicales.fr/mesh/D004421?mesh_terms=Reproducibility+of+Results&page=5#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Dystonie", "description": "Peut-on prévenir la dystonie ?\nLe stress influence-t-il la dystonie ?\nLes exercices physiques aident-ils à prévenir la dystonie ?\nY a-t-il des facteurs environnementaux à éviter ?\nL'éducation sur la dystonie est-elle utile ?", "url": "https://questionsmedicales.fr/mesh/D004421?mesh_terms=Reproducibility+of+Results&page=5#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Dystonie", "description": "Quels traitements sont disponibles pour la dystonie ?\nLes médicaments sont-ils efficaces pour la dystonie ?\nLa toxine botulique est-elle utilisée pour la dystonie ?\nLa thérapie physique aide-t-elle la dystonie ?\nQuand la chirurgie est-elle envisagée pour la dystonie ?", "url": "https://questionsmedicales.fr/mesh/D004421?mesh_terms=Reproducibility+of+Results&page=5#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Dystonie", "description": "Quelles complications peuvent survenir avec la dystonie ?\nLa dystonie peut-elle affecter la qualité de vie ?\nY a-t-il des risques psychologiques associés à la dystonie ?\nLa dystonie peut-elle entraîner des blessures ?\nLes complications sont-elles réversibles ?", "url": "https://questionsmedicales.fr/mesh/D004421?mesh_terms=Reproducibility+of+Results&page=5#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Dystonie", "description": "Quels sont les facteurs de risque de la dystonie ?\nL'âge influence-t-il le risque de dystonie ?\nLes femmes sont-elles plus à risque de dystonie ?\nLes maladies neurologiques augmentent-elles le risque ?\nLes médicaments peuvent-ils être un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D004421?mesh_terms=Reproducibility+of+Results&page=5#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on la dystonie ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'examen clinique et l'historique médical, parfois complété par des tests d'imagerie." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour la dystonie ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des IRM cérébrales et des électromyogrammes peuvent être réalisés pour évaluer la fonction musculaire." } }, { "@type": "Question", "name": "La dystonie est-elle héréditaire ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Certaines formes de dystonie peuvent être héréditaires, nécessitant une évaluation génétique." } }, { "@type": "Question", "name": "Quels spécialistes consultent pour la dystonie ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les neurologues sont les principaux spécialistes impliqués dans le diagnostic de la dystonie." } }, { "@type": "Question", "name": "Y a-t-il des critères spécifiques pour le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des critères cliniques spécifiques, comme le type de mouvements involontaires, sont utilisés." } }, { "@type": "Question", "name": "Quels sont les symptômes courants de la dystonie ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des contractions musculaires, des mouvements anormaux et des postures tordues." } }, { "@type": "Question", "name": "La dystonie affecte-t-elle la parole ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la dystonie peut affecter la parole, entraînant des difficultés d'élocution." } }, { "@type": "Question", "name": "Les symptômes de la dystonie sont-ils constants ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Non, les symptômes peuvent varier en intensité et peuvent être exacerbés par le stress." } }, { "@type": "Question", "name": "La dystonie peut-elle causer de la douleur ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les contractions musculaires peuvent entraîner des douleurs et de l'inconfort." } }, { "@type": "Question", "name": "Y a-t-il des types spécifiques de dystonie ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il existe plusieurs types, comme la dystonie focale et la dystonie généralisée." } }, { "@type": "Question", "name": "Peut-on prévenir la dystonie ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de méthode de prévention garantie, mais un mode de vie sain peut aider." } }, { "@type": "Question", "name": "Le stress influence-t-il la dystonie ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress peut aggraver les symptômes de la dystonie, donc la gestion du stress est importante." } }, { "@type": "Question", "name": "Les exercices physiques aident-ils à prévenir la dystonie ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Des exercices réguliers peuvent améliorer la condition physique et potentiellement réduire les symptômes." } }, { "@type": "Question", "name": "Y a-t-il des facteurs environnementaux à éviter ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les toxines environnementales et les traumatismes peut réduire le risque de dystonie." } }, { "@type": "Question", "name": "L'éducation sur la dystonie est-elle utile ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une meilleure compréhension de la maladie peut aider les patients à gérer leurs symptômes." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour la dystonie ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des médicaments, des thérapies physiques et parfois la chirurgie." } }, { "@type": "Question", "name": "Les médicaments sont-ils efficaces pour la dystonie ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des médicaments comme les anticholinergiques peuvent réduire les symptômes chez certains patients." } }, { "@type": "Question", "name": "La toxine botulique est-elle utilisée pour la dystonie ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les injections de toxine botulique peuvent aider à réduire les spasmes musculaires." } }, { "@type": "Question", "name": "La thérapie physique aide-t-elle la dystonie ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la thérapie physique peut améliorer la mobilité et réduire la douleur associée." } }, { "@type": "Question", "name": "Quand la chirurgie est-elle envisagée pour la dystonie ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "La chirurgie est envisagée lorsque les traitements médicamenteux échouent à soulager les symptômes." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec la dystonie ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des douleurs chroniques, des troubles de la posture et des difficultés fonctionnelles." } }, { "@type": "Question", "name": "La dystonie peut-elle affecter la qualité de vie ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la dystonie peut significativement affecter la qualité de vie en limitant les activités quotidiennes." } }, { "@type": "Question", "name": "Y a-t-il des risques psychologiques associés à la dystonie ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les patients peuvent éprouver de l'anxiété et de la dépression en raison de leur condition." } }, { "@type": "Question", "name": "La dystonie peut-elle entraîner des blessures ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les mouvements involontaires peuvent causer des chutes et des blessures accidentelles." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être gérées ou améliorées avec un traitement approprié." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque de la dystonie ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux, des traumatismes crâniens et certaines maladies neurologiques." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque de dystonie ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la dystonie peut survenir à tout âge, mais certains types apparaissent plus souvent chez les jeunes adultes." } }, { "@type": "Question", "name": "Les femmes sont-elles plus à risque de dystonie ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Certaines études suggèrent que les femmes peuvent être plus susceptibles de développer certains types de dystonie." } }, { "@type": "Question", "name": "Les maladies neurologiques augmentent-elles le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des conditions comme la maladie de Parkinson peuvent augmenter le risque de dystonie." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils être un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains médicaments, comme les antipsychotiques, peuvent induire des symptômes de dystonie." } } ] } ] }

Sources (10000 au total)

Twelve-month results of the ADAPT randomized controlled trial: Reproducibility and sustainability of advanced hybrid closed-loop therapy outcomes versus conventional therapy in adults with type 1 diabetes.

To reassess the 6-month efficacy and to assess the 12-month sustained efficacy of the MiniMed™ 780G advanced hybrid closed-loop automated insulin delivery (AID) system compared to multiple daily injec... The ADAPT study was a prospective, multicentre, open-label, randomized control trial in people with type 1 diabetes, with a glycated haemoglobin (HbA1c) concentration of at least 8.0% (64 mmol/mol), o... A total of 39 SWITCH and 36 SUSTAIN participants entered the continuation phase. In the SWITCH group, HbA1c was significantly decreased by -1.4% (95% confidence interval [CI] -1.7% to -1.1%; P < 0.001... ADAPT study phase glycaemic improvements were reproduced and sustained in the continuation phase, supporting the early adoption of AID therapy in people with type 1 diabetes not meeting glucose target...

Reproducibility and intratumoral heterogeneity of the PAM50 breast cancer assay.

The PAM50 assay is used routinely in clinical practice to determine breast cancer prognosis and management; however, research assessing how technical variation and intratumoral heterogeneity contribut... We evaluated the impact of intratumoral heterogeneity on the reproducibility of results for the PAM50 assay by testing RNA extracted from formalin-fixed paraffin embedded breast cancer blocks sampled ... Technical replicates (N = 144) achieved 93% agreement for ROR-P group and 90% agreement on PAM50 subtype. For spatially distinct biological replicates (N = 40 intratumoral replicates), agreement was l... The PAM50 assay achieved very high technical reproducibility for breast cancer subtyping and ROR-P, but intratumoral heterogeneity is revealed by the assay in a small proportion of cases....

Reproducibility assessment of uptake on dedicated breast PET for noise discrimination.

Dedicated breast PET (dbPET) systems have improved the detection of small breast cancers but have increased false-positive diagnoses due to an increased chance of noise detection. This study examined ... This study included 21 patients with newly diagnosed breast cancer who underwent [... A total of 213 indexed uptake spots were identified on dbPET-1, including 152, 15, 6, 6, and 34 lesions classified as BI-RADS MRI categories 1, 2, 4b, 4c, and 5, respectively. Overall, 31.9% of the in... Our results demonstrated that reproducibility assessment helped reduce false-positive findings caused by noise on dbPET without lowering the sensitivity for malignancy. While subjective visual assessm...

Interlaboratory reproducibility of a touch-transfer assay for the assessment of antimicrobial surfaces.

Various assay methods have been developed to study antimicrobial activity based on contamination of surfaces with different amounts of liquid bacterial suspensions. Since surfaces with frequent hand c... To investigate a surface previously confirmed to display antimicrobial activity even after drying of small volumes of bacterial suspension (Egger antimicrobial surfaces: EAS) under conditions modellin... EAS, an antimicrobial copper alloy, as well as a negative control were examined to assess interlaboratory test reproducibility.... Significantly fewer bacteria on EAS after touch transfer and some differences in the touch transmission were detected between the two laboratories. However, an identical assessment of effectiveness fo... Since, in the real world of a hospital, organisms are typically transferred between dry surfaces, further standardization of the touch-transfer method is worthwhile for a better understanding of the e...

Repeatability and reproducibility of a hyperspectral imaging system for in vivo color evaluation.

Color imaging is a tried and true method for the evaluation of cosmetic and dermatological effects, but it fails to capture all the information in a scene's spectral reflectance. For this reason, ther... We developed a novel HyperSpectral Imager (HSI) able to take in vivo full-face format images as a next generation instrument for skin color measurement and beyond. Here, we report part of the results ... We find that the measurements from the HSI provide repeatability and reproducibility as good or better than those of our previous benchmark devices.... From these results, we conclude that not only is the HSI suitable for use in color evaluation studies, but also that it gives operational advantages over the previous generation of evaluation instrume...